During the past decade, Klinikum rechts der Isar der TU München; Augenklinik conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum rechts der Isar der TU München; Augenklinik" are "Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Cornea Transplant" (1 trials), "Corneal Diseases" (1 trials) and "Corneal Graft Rejection" (1 trials). Many other conditions were trialed in "Klinikum rechts der Isar der TU München; Augenklinik" in a lesser frequency.

Most popular intervention types in "Klinikum rechts der Isar der TU München; Augenklinik" are "Drug" (6 trials), "Other" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "LX201" (2 trials), "Lampalizumab" (2 trials), "Placebo" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum rechts der Isar der TU München; Augenklinik" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum rechts der Isar der TU München; Augenklinik". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum rechts der Isar der TU München; Augenklinik, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum rechts der Isar der TU München; Augenklinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".